Welcome

Dr. Reddy’s, Russia Get India Approval for Human Vaccine Trial

Oct. 17, 2020, 11:48 AM

Dr. Reddy’s Laboratories Ltd. and Russia’s sovereign wealth fund got approval to conduct human clinical trials of their coronavirus vaccine in India, according to an emailed statement from one of the vaccine developers.

The phase 2/3 trial will be a multi-center and randomized controlled study that will include safety and immunogenicity, according to the statement by the Russian Direct Investment Fund.

The Kremlin has pinned great hopes on the Sputnik V vaccine, which President Vladimir Putin is promoting as the first registered inoculation in the world, to help establish Russia as a leader in the race to subdue the global ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.